SciTree project
- 1. SciTree Meeting place for science and business
- 2. New technologies (materials, substances, technique) are a basis of contemporary economy and an ideal target for investment. Science produces plenty of new technologies, which can be converted into business product, and create revenue. However investors have no access to information about 99% of new technologies. They know about these technologies only when somebody else has used them to bring new product to the market. Problem
- 3. Scientific networks have no contact or crossing with investors’ networks. Scientific Output comes in form of verbose papers, inaccessible and incomprehensible for people outside of academy. Investors’ Input comes in form of simple and short presentations and business plans, which scientists are not used to make. Reasons
- 4. SciTree – a web platform for collaboration between scientists and investors • Changing scientific Output :short statement about new technology (25 words)+ link to a paper • Investors can choose a technology they want to turn into a product • Investors can set a task for a research group (to develop a new material, f.e.) • Constant monitoring of new technologies Solution
- 5. Over 5 million scientists are developing new technologies (biology, medicine, materials, etc). Scientists get financing by writing articles for peer-review journals and project proposals for research funds (government organizations), which takes up to 50% of their working time. This is ineffective usage of their time and brainpower. Companies spend up to 43% of revenue on R&D (Allergan – 43.4%, Eriksson – 24.9%). New technologies are important for progress and successful competition. However these investments do not guarantee good results, as discoveries in science happen irregularly. Thus, it is highly expensive and not that effective to have an R&D department in a company. With SciTree entire science can be used as your own R&D department. Outsource your R&D anywhere. Market
- 6. Social network for scientists, 1.7 million users. Deficiencies: scientists only, output in a form of big articles. Social network for scientists, 1.8 million users. Deficiencies: scientists only, output in a form of big articles. A consulting firm, helping to find objects of investment. Deficiencies: high price, lack of transparency, lack of direct contacts with scientists. Competitors
- 7. Elena Kalmykova, CEO PhD in Philosophy (Uppsala University, Sweden). Graduated from Oriental and Philosophy Faculties at Saint-Petersburg State University. Courses attended: Technology Entrepreneurship (Stanford University), Researchers and Leadership (Swedish Institute). Published over 20 papers on the topics such as structure of scientific knowledge and communication in science. Work experience in web-projects: Electric Jungle (Sun Microsystems), SMM, web design, member of Wallenberg Calendar team. John Noel M. Viaña BS in Molecular Biology and Biotechnology (University of the Philippines - Diliman). Has worked at the Laboratory of Molecular and Cell Biology at the National Institute of Molecular Biology and Biotechnology, UP Diliman Member of international honor societies (Phi Kappa Phi and Phi Sigma Biological Sciences Honor Society). Courses attended: Technological Entrepreneurship at Stanford’s Venture Lab. Team
- 8. Investors:pay for Advertising: targeted ads subscription (golden and (lab equipment, laptops etc) silver membership), exclusive access to information Investors: pay for review of dynamics of field Scientists: pay to promote development, analytics, your news or team consulting and selection of teams for investment Investors and visitors: Universities: pay for donate for a specific research, advertising academic jobs we keep 5% of donation Marketing
- 10. +46 709 429 138 team@scitree.org Best regards, Elena Kalmykova Contact information